WHO prequalification of medicines: application fees
M
Information for manufacturers who experience delays in national registration of prequalified medicines
M
Information for manufacturers who experience delays in national registrations of prequalified medicines
Acceptance of non-plant-derived-artemisinin offers potential to increase access to malaria treatment
M
Speeding up access to quality medicines in Africa
M
http://www.who.int/features/2013/accelerated_registration/en/